Titre
Uptake of new treatment strategies for deep vein thrombosis: an international audit.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Auteur(s)
Aujesky, D.A.
Auteure/Auteur
Cornuz, J.
Auteure/Auteur
Bosson, J.L.
Auteure/Auteur
Bounameaux, H.
Auteure/Auteur
Emmerich, J.
Auteure/Auteur
Hull, R.D.
Auteure/Auteur
Mackay, E.
Auteure/Auteur
Perrier, A.
Auteure/Auteur
Quan, H.
Auteure/Auteur
Tsuyuki, R.T.
Auteure/Auteur
Ghali, W.A.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1353-4505
Statut éditorial
Publié
Date de publication
2004
Volume
16
Numéro
3
Première page
193
Dernière page/numéro d’article
200
Peer-reviewed
Oui
Langue
anglais
Résumé
OBJECTIVE: Study of the uptake of new medical technologies provides useful information on the transfer of published evidence into usual practice. We conducted an audit of selected hospitals in three countries (Canada, France, and Switzerland) to identify clinical predictors of low-molecular-weight (LMW) heparin use and outpatient treatment, and to compare the pace of uptake of these new therapeutic approaches across hospitals. DESIGN: Historical review of medical records. SETTING AND PARTICIPANTS: We reviewed the medical records of 3043 patients diagnosed with deep vein thrombosis (DVT) in five Canadian, two French, and two Swiss teaching hospitals from 1994 to 1998. Measures. We explored independent clinical variables associated with LMW heparin use and outpatient treatment, and determined crude and adjusted rates of LMW heparin use and outpatient treatment across hospitals. RESULTS: For the years studied, the overall rates of LMW heparin use and outpatient treatment in the study sample were 34.1 and 15.8%, respectively, with higher rates of use in later years. Many comorbidities were negatively associated with outpatient treatment, and risk-adjusted rates of use of these new approaches varied significantly across hospitals. CONCLUSION: There has been a relatively rapid uptake of LMW heparins and outpatient treatment for DVT in their early years of availability, but the pace of uptake has varied considerably across hospitals and countries.
PID Serval
serval:BIB_05930D25F075
PMID
Open Access
Oui
Date de création
2008-03-05T14:56:55.693Z
Date de création dans IRIS
2025-05-20T20:23:51Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
REF.pdf
Version du manuscrit
published
Taille
114.68 KB
Format
Adobe PDF
PID Serval
serval:BIB_05930D25F075.P001
URN
urn:nbn:ch:serval-BIB_05930D25F0757
Somme de contrôle
(MD5):4b9b3ed5f263e8c88c0664a428315efc